NOVEL CHALCONE-BASED CHEMOTHERAPEUTIC COMPOUND FOR TRIPLE NEGATIVE BREAST CANCER
or a pharmaceutically acceptable salt or solvate thereof. In certain aspects, provided herein are compositions comprising any of the compounds provided herein. In certain aspects, provided herein are methods for the treatment of cancer in a subject in need thereof comprising administering to the subject an effective amount of any of the compounds or compositions provided herein..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 17. Dez. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
KHALIL ASHRAF [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-12-17, Last update posted on www.tib.eu: 2023-11-30, Last updated: 2023-12-08 |
|---|
| Patentnummer: |
US2020392119 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA010077901 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA010077901 | ||
| 003 | DE-627 | ||
| 005 | 20231208115059.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA010077901 | ||
| 035 | |a (EPA)US2020392119 | ||
| 035 | |a (EPA)73745888 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a KHALIL ASHRAF |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a NOVEL CHALCONE-BASED CHEMOTHERAPEUTIC COMPOUND FOR TRIPLE NEGATIVE BREAST CANCER |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-12-17, Last update posted on www.tib.eu: 2023-11-30, Last updated: 2023-12-08 | ||
| 520 | |a or a pharmaceutically acceptable salt or solvate thereof. In certain aspects, provided herein are compositions comprising any of the compounds provided herein. In certain aspects, provided herein are methods for the treatment of cancer in a subject in need thereof comprising administering to the subject an effective amount of any of the compounds or compositions provided herein. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C07C: Acyclic or carbocyclic compounds (macromolecular compounds c08;production of organic compounds by electrolysis or electrophoresis c25b0003000000, c25b0007000000) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a AL MOUSTAFA ALA-EDDIN |4 aut | |
| 700 | 0 | |a ELKHALIFA DANA H |4 aut | |
| 700 | 0 | |a ALALI FERAS |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 17. Dez. |
| 773 | 1 | 8 | |g year:2020 |g day:17 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/73745888/publication/US2020392119A1?q=US2020392119 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2020 |b 17 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 17 |c 12 | ||